Clinical Trial Capacity
The goal of ACTIV is to develop a research strategy for prioritizing and speeding development of the most promising COVID-19 vaccines and treatments.
The Clinical Trial Capacity Working Group is focused on:
- Identifying data from different populations and disease stages
- Leveraging infrastructure and expertise from across NIH and non-NIH networks and clinical research organizations
- Establishing a coordinated mechanism across networks to expedite trials
- Tracking incidence across sites and projecting future capacity